File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Lycium barbarum Extract Enhanced Neuroplasticity and Functional Recovery in 5xFAD Mice via Modulating Microglial Status of the Central Nervous System

TitleLycium barbarum Extract Enhanced Neuroplasticity and Functional Recovery in 5xFAD Mice via Modulating Microglial Status of the Central Nervous System
Authors
Keywords5xFAD mice
Alzheimer's pathology
central nervous system
Lycium barbarum extract
neuroinflammation
neuroprotective microglial phenotype
retina
spinal cord
Issue Date2024
Citation
CNS Neuroscience and Therapeutics, 2024, v. 30, n. 11, article no. e70123 How to Cite?
AbstractObjective: Alzheimer's disease (AD) is the most prevalent neurodegenerative disease with limited treatment options. This study aimed to investigate the effects of Lycium barbarum extract (LBE), a Chinese herb, on the central nervous system (CNS)—including the retina, brain, and spinal cord—in 5xFAD transgenic mice after the onset of AD. Methods: Starting at 6 months of age, 5xFAD mice received daily intragastric gavage of LBE (2 g/kg) for 2 months. At 8 months, behavioral tests were conducted to assess cognition, motor function, and visual function. These included the Morris water maze, novel object recognition, and Y-maze tests for cognition; the beam walking balance and clasping tests for motor function; and electroretinogram (ERG) for visual function. Immunohistochemistry, western blotting, and ELISA were used to evaluate Aβ deposition, microglial morphology, neuroinflammation, and neuroprotective signaling pathways. Primary microglia and the IMG cell line were used to study LBE's effects on Aβ uptake and degradation in vitro. Results: After 2 months of LBE treatment, the decline in cognition, motor, and visual functions in 5xFAD mice was significantly slowed. Microglia in the brain, spinal cord, and retina exhibited a neuroprotective state, with reduced Aβ deposition, decreased inflammatory cytokine levels (e.g., TNF-α, IL-1β, IL-6), increased Arg-1/iNOS ratio, and enhanced phagocytic capacity. LBE also promoted Aβ uptake and degradation in primary microglia and the IMG cell line. Neuroprotective signals such as p-Akt, p-Erk1/2, and p-CREB were elevated. Additionally, LBE treatment restored synaptic protein expression and enhanced neuroplasticity. Conclusion: The findings suggest that LBE treatment can enhance neuroplasticity, reduce systemic inflammation, and improve phagocyte clearance of Aβ deposition via inducing a neuroprotective microglial phenotype throughout CNS. As an upper-class Chinese medicine, appropriate intake of LBE may serve as a beneficial antiaging strategy for AD.
Persistent Identifierhttp://hdl.handle.net/10722/354407
ISSN
2023 Impact Factor: 4.8
2023 SCImago Journal Rankings: 1.473

 

DC FieldValueLanguage
dc.contributor.authorSun, Zhongqing-
dc.contributor.authorLiu, Jinfeng-
dc.contributor.authorChen, Zihang-
dc.contributor.authorSo, Kwok Fai-
dc.contributor.authorHu, Yong-
dc.contributor.authorChiu, Kin-
dc.date.accessioned2025-02-07T08:48:24Z-
dc.date.available2025-02-07T08:48:24Z-
dc.date.issued2024-
dc.identifier.citationCNS Neuroscience and Therapeutics, 2024, v. 30, n. 11, article no. e70123-
dc.identifier.issn1755-5930-
dc.identifier.urihttp://hdl.handle.net/10722/354407-
dc.description.abstractObjective: Alzheimer's disease (AD) is the most prevalent neurodegenerative disease with limited treatment options. This study aimed to investigate the effects of Lycium barbarum extract (LBE), a Chinese herb, on the central nervous system (CNS)—including the retina, brain, and spinal cord—in 5xFAD transgenic mice after the onset of AD. Methods: Starting at 6 months of age, 5xFAD mice received daily intragastric gavage of LBE (2 g/kg) for 2 months. At 8 months, behavioral tests were conducted to assess cognition, motor function, and visual function. These included the Morris water maze, novel object recognition, and Y-maze tests for cognition; the beam walking balance and clasping tests for motor function; and electroretinogram (ERG) for visual function. Immunohistochemistry, western blotting, and ELISA were used to evaluate Aβ deposition, microglial morphology, neuroinflammation, and neuroprotective signaling pathways. Primary microglia and the IMG cell line were used to study LBE's effects on Aβ uptake and degradation in vitro. Results: After 2 months of LBE treatment, the decline in cognition, motor, and visual functions in 5xFAD mice was significantly slowed. Microglia in the brain, spinal cord, and retina exhibited a neuroprotective state, with reduced Aβ deposition, decreased inflammatory cytokine levels (e.g., TNF-α, IL-1β, IL-6), increased Arg-1/iNOS ratio, and enhanced phagocytic capacity. LBE also promoted Aβ uptake and degradation in primary microglia and the IMG cell line. Neuroprotective signals such as p-Akt, p-Erk1/2, and p-CREB were elevated. Additionally, LBE treatment restored synaptic protein expression and enhanced neuroplasticity. Conclusion: The findings suggest that LBE treatment can enhance neuroplasticity, reduce systemic inflammation, and improve phagocyte clearance of Aβ deposition via inducing a neuroprotective microglial phenotype throughout CNS. As an upper-class Chinese medicine, appropriate intake of LBE may serve as a beneficial antiaging strategy for AD.-
dc.languageeng-
dc.relation.ispartofCNS Neuroscience and Therapeutics-
dc.subject5xFAD mice-
dc.subjectAlzheimer's pathology-
dc.subjectcentral nervous system-
dc.subjectLycium barbarum extract-
dc.subjectneuroinflammation-
dc.subjectneuroprotective microglial phenotype-
dc.subjectretina-
dc.subjectspinal cord-
dc.titleLycium barbarum Extract Enhanced Neuroplasticity and Functional Recovery in 5xFAD Mice via Modulating Microglial Status of the Central Nervous System-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/cns.70123-
dc.identifier.pmid39564756-
dc.identifier.scopuseid_2-s2.0-85209648903-
dc.identifier.volume30-
dc.identifier.issue11-
dc.identifier.spagearticle no. e70123-
dc.identifier.epagearticle no. e70123-
dc.identifier.eissn1755-5949-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats